epitope corresponding to amino acids 1-93 representing full length DAP10 of human origin
Modification Notes
DAP10, a transmembrane type 1 protein, is predominantly expressed in hematopoietic cells (1). On SDS-PAGE, DAP10 migrates slightly slower than expected due to glycosylation (1). DAP10 forms an activating receptor complex with its physiological partner, NKG2D (1). NKG2D is an activating receptor that initiates Natural Killer and T-cell mediated cytotoxicity against tumors expressing its ligands MICA and MICB (2). The DAP10-NKG2D complex, as well as MICA and MICB, are stress-inducible molecules expressed in epithelial tumors (3). Both DAP10 and NKG2D contain inhibition motifs in their cytoplasmic domains that recruit tyrosine-phosphatases, resulting in the inactivation of Natural Killer cells (4). The cytoplasmic region of DAP10 also contains a binding site for the SH2 domain of the p85 subunit of PI 3-kinase which suggests a role for DAP10 as a signal transducer leading to PI 3-kinase activation (1,5).
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPIFELISA
recommended for detection of DAP10 of mouse, rat and human origin by WB, IP, IF and ELISA:
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
epitope corresponding to amino acids 1-93 representing full length DAP10 of human origin
Tissue Specificity
epitope corresponding to amino acids 1-93 representing full length DAP10 of human origin